SC209, an ADC cytotoxin extracted from patent WO2021247798, is used in synthesis of anti- EGFR antibody-drug conjugate ADC. SC209 is a metabolite of STRO-002.
Form:Solid
사양
사양 및 순도
≥99%
생화학 및 생리적 메커니즘
SC209, an ADC cytotoxin extracted from patent WO2021247798, is used in synthesis of anti- EGFR antibody-drug conjugate ADC. SC209 is a metabolite of STRO-002.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.